Cover Image
市場調查報告書

馬來西亞的醫藥品市場分析

Analysis of the Pharmaceutical Market in Malaysia

出版商 Frost & Sullivan 商品編碼 332904
出版日期 內容資訊 英文 65 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
馬來西亞的醫藥品市場分析 Analysis of the Pharmaceutical Market in Malaysia
出版日期: 2015年06月16日 內容資訊: 英文 65 Pages
簡介

本報告提供馬來西亞的醫藥品市場相關調查分析、市場概要、需求趨勢、推動因素與阻礙因素、主要企業、未來發展預測相關的系統性資訊。

摘要整理

馬來西亞的醫療市場概要

  • 馬來西亞的醫療市場概要
  • 馬來西亞的公共、民間醫療制度概要
  • 馬來西亞的醫療制度的研究
  • 民間醫療制度的研究
  • 未來的障礙

馬來西亞的醫療市場需求趨勢

  • 家計收入的分佈
  • 馬來西亞醫院市場主要推動因素:老年人口的增加
  • 馬來西亞的民間醫院市場區隔的主要推動因素:醫療旅遊觀光事業
  • 馬來西亞醫院市場主要推動因素:慢性疾病、文明病

馬來西亞的醫藥品市場概要

  • 馬來西亞的醫藥品市場概要
  • 馬來西亞的醫藥品市場收益預測
  • 醫藥品市場結構要素:比率
  • 馬來西亞的醫藥品市場:區分
  • 馬來西亞的清真醫療市場
  • 馬來西亞的法規形勢
  • 馬來西亞的醫藥品市場主要推動因素
  • GST對馬來西亞的醫藥品市場的影響

推動因素與阻礙因素:馬來西亞的醫藥品市場

  • 推動因素
  • 阻礙因素

醫藥品市場主要企業簡介

  • 馬來西亞的醫藥品市場當地企業
  • CCM Pharmaceuticals Sdn Bhd
  • Kotra Pharma (M) Sdn Bhd
  • Pharmaniaga Berhad
  • YSP Industries (M) Sdn Bhd
  • Hovid Berhad
  • 馬來西亞的醫藥品市場跨國公司
  • Pfizer Malaysia
  • Merck Sharp & Dohme (MSD)
  • Eli Lilly
  • GlaxoSmithKline (GSK)
  • Johnson & Johnson Sdn Bhd

醫藥品市場主要企業分析

  • 大環境分析
  • 馬來西亞的醫藥品市場波特的五力分析

馬來西亞的醫藥品市場未來

  • 馬來西亞的醫藥品市場未來:主要領域
  • 免責聲明

關於Frost&Sullivan

目錄
Product Code: 9AB9-00-22-00-00

Attractiveness and Hurdles for Stakeholders in the Next 5 Years

The growing population base, driven by increased life expectancy and domestic investment, is expected to continuously accelerate GDP in Malaysia. Significant growth of healthcare expenditure is expected in the country to facilitate the improvement of medical access and provide companies with revenue-earning opportunities from 2015. Positive macroeconomic and healthcare market trends are expected to fast-track the pharmaceutical market in Malaysia. The study explores the broad competitive landscape, demand dynamics, and regulatory environment that investors must consider while entering this pharmaceutical market.

Table of Contents

1. ANALYSIS OF THE PHARMACEUTICAL MARKET IN MALAYSIA

Executive Summary

  • 1. Key Findings
  • 2. Key Questions this Study will Answer

Overview of the Malaysian Healthcare Market

  • 1. Overview of the Malaysian Healthcare Market
  • 2. Overview of the Malaysian Healthcare Market (continued)
  • 3. Overview of the Malaysian Healthcare Market (continued)
  • 4. Overview of the Malaysian Healthcare Market (continued)
  • 5. Overview of the Malaysian Healthcare Market (continued)
  • 6. Overview of the Malaysian Healthcare Market (continued)
  • 7. Overview of the Malaysian Healthcare Market (continued)
  • 8. Overview of Malaysian Public and Private Healthcare Systems
  • 9. Overview of Malaysian Public and Private Healthcare Systems (continued)
  • 10. Algorithm of Malaysian Healthcare Systems
  • 11. Algorithm of Private Healthcare Systems
  • 12. Future Roadblocks

Demand Dynamics in the Malaysian Healthcare Market

  • 1. Distribution of Household Income Up to 2012
  • 2. Key Driver in the Malaysian Hospital Market-Growing Admission of Elderly Population
  • 3. Key Driver in the Malaysian Private Hospital Segment-Medical Tourism
  • 4. Key Drivers in the Malaysian Hospital Market-Chronic and Lifestyle Diseases

Overview of the Malaysian Pharmaceutical Market

  • 1. Overview of the Malaysian Pharmaceutical Market
  • 2. Revenue Forecast for the Malaysian Pharmaceutical Market
  • 3. Pharmaceutical Market Components by Percentage
  • 4. Malaysian Pharmaceutical Market-Segmentation
  • 5. Malaysian Pharmaceutical Market-Segmentation (continued)
  • 6. Halal Medicine Market in Malaysia
  • 7. Malaysian Regulatory Landscape
  • 8. Key Driver in the Malaysian Pharmaceutical Market-NKEA
  • 9. Impact of GST on Malaysian Pharmaceutical Market

Drivers and Restraints-Malaysian Pharmaceutical Market

  • 1. Drivers
  • 2. Restraints

Profiles of Pharmaceutical Market Participants

  • 1. Home-grown Participants in the Malaysian Pharmaceutical Market
  • 2. CCM Pharmaceuticals Sdn Bhd
  • 3. Kotra Pharma (M) Sdn Bhd
  • 4. Pharmaniaga Berhad
  • 5. YSP Industries (M) Sdn Bhd
  • 6. Hovid Berhad
  • 7. MNC Participants in the Malaysian Pharmaceutical Market
  • 8. Pfizer Malaysia
  • 9. Merck Sharp & Dohme (MSD)
  • 10. Eli Lilly
  • 11. GlaxoSmithKline (GSK)
  • 12. Johnson & Johnson Sdn Bhd

Analysis of the Pharmaceutical Market Participants

  • 1. PESTLE Analysis
  • 2. Porter Five Forces Analysis for the Malaysian Pharmaceutical Market

The Future of the Malaysian Pharmaceutical Market

  • 1. The Future of the Malaysian Pharmaceutical Market-Key Focus Areas
  • 2. Legal Disclaimer

The Frost & Sullivan Story

  • 1. The Frost & Sullivan Story
  • 2. Value Proposition: Future of Your Company & Career
  • 3. Global Perspective
  • 4. Industry Convergence
  • 5. 360° Research Perspective
  • 6. Implementation Excellence
  • 7. Our Blue Ocean Strategy
Back to Top